Cargando…

The Kidney in Heart Failure

Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death.  The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.   The Kidney in Heart Failure focuses on the changes that occ...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Bakris, George L. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer US : Imprint: Springer, 2012.
Edición:1st ed. 2012.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-1-4614-3694-2
003 DE-He213
005 20220116202810.0
007 cr nn 008mamaa
008 120709s2012 xxu| s |||| 0|eng d
020 |a 9781461436942  |9 978-1-4614-3694-2 
024 7 |a 10.1007/978-1-4614-3694-2  |2 doi 
050 4 |a RC902-918 
072 7 |a MJR  |2 bicssc 
072 7 |a MED055000  |2 bisacsh 
072 7 |a MJR  |2 thema 
082 0 4 |a 616.61  |2 23 
245 1 4 |a The Kidney in Heart Failure  |h [electronic resource] /  |c edited by George L. Bakris. 
250 |a 1st ed. 2012. 
264 1 |a New York, NY :  |b Springer US :  |b Imprint: Springer,  |c 2012. 
300 |a XIV, 250 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Epidemiology of chronic kidney disease in heart failure -- Anemia and cardiovascular risk in the kidney disease patient -- Renal hemodynamic changes in heart failure -- Changes in kidney function following heart failure treatment: Focus on RAS Blockade -- Extracellular fluid volume in the hypoalbuminemic diabetic patient -- B-Type natriuretic peptide: Beyond a diagnostic criteria -- Hyperkalemia risk and treatment of heart failure -- Management of heart failure with renal artery ischemia -- Treatment of hypertension in heart failure with renal artery ischemia: Role of the kidney -- Renal consequences of prostaglandin inhibition in heart failure -- Edema mechanisms in the heart failure patient and treatment options -- Ultrafiltration for volume control in decompensated heart failure / Combination therapies -- Cost benefits of minimizing pill counts and dosing regimens -- New markers of vascular risk -- Dietary paradoxes to optimize cardiovascular risk management in CKD. 
520 |a Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death.  The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.   The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart.  This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management.  In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included.  Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions.   This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient. 
650 0 |a Nephrology. 
650 0 |a Cardiology. 
650 1 4 |a Nephrology. 
650 2 4 |a Cardiology. 
700 1 |a Bakris, George L.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781461436935 
776 0 8 |i Printed edition:  |z 9781461436959 
776 0 8 |i Printed edition:  |z 9781489998118 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-1-4614-3694-2  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)